Ervebo Europska Unija - hrvatski - EMA (European Medicines Agency)

ervebo

merck sharp & dohme b.v.  - рекомбинантный virus везикулярного стоматита (soj indiana) s brisanje koverti glikoprotein, zamijenjen zair ebole (soj киквите 1995) površinski glikoprotein - Геморрагическая groznice ebole - cjepiva - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. korištenje ervebo moraju biti u skladu sa službenim preporukama.

Lyfnua Europska Unija - hrvatski - EMA (European Medicines Agency)

lyfnua

merck sharp & dohme b.v. - gefapixant - cough - kašalj i hladno pripremanje - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.

Aerius Europska Unija - hrvatski - EMA (European Medicines Agency)

aerius

n.v. organon - dcsloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminici za sistemsku primjenu, - Эриус je propisan za ublažavanje simptoma povezanih s:alergijski rinitis;osip.

Azomyr Europska Unija - hrvatski - EMA (European Medicines Agency)

azomyr

n.v. organon - dcsloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminici za sistemsku primjenu, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.

Fosavance Europska Unija - hrvatski - EMA (European Medicines Agency)

fosavance

n.v. organon - alendronic kiseline, colecalciferol - osteoporoza, postmenopauzalna - lijekovi za liječenje bolesti kostiju - liječenje osteoporoze u postmenopauzi u bolesnika s rizikom od insuficijencije vitamina d. fosavance smanjuje rizik od prijeloma kralježnice i kukova .

Neoclarityn Europska Unija - hrvatski - EMA (European Medicines Agency)

neoclarityn

n.v. organon - dcsloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminici za sistemsku primjenu, - neoclarityn navodi za ublažavanje simptoma povezanih s:alergijske rhinitisurticaria.

Vantavo (previously Alendronate sodium and colecalciferol, MSD) Europska Unija - hrvatski - EMA (European Medicines Agency)

vantavo (previously alendronate sodium and colecalciferol, msd)

n.v. organon - alendronic kiseline, colecalciferol - osteoporoza, postmenopauzalna - lijekovi za liječenje bolesti kostiju - liječenje osteoporoze u postmenopauzi u bolesnika s rizikom od insuficijencije vitamina d. vantavo smanjuje rizik od prijeloma kralježnice i kukova . liječenje постменопаузального osteoporoze kod bolesnika koji ne primaju vitamina d prehrani i rizika vitamina d bubrega. vantavo smanjuje rizik od prijeloma kralježnice i kukova .

Pifeltro Europska Unija - hrvatski - EMA (European Medicines Agency)

pifeltro

merck sharp & dohme b.v. - doravirine - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Qinlock Europska Unija - hrvatski - EMA (European Medicines Agency)

qinlock

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - tumori gastrointestinalnog stroma - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Elonva Europska Unija - hrvatski - EMA (European Medicines Agency)

elonva

n.v. organon - korifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - spolni hormoni i modulatori genitalnog sustava, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).